Treatment of bacterial diseases with granulocyte-macrophage colony
stimulating factor
    9.
    发明授权
    Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor 失效
    用粒细胞巨噬细胞集落刺激因子治疗细菌性疾病

    公开(公告)号:US5162111A

    公开(公告)日:1992-11-10

    申请号:US892123

    申请日:1986-07-30

    摘要: Subjects suffering from infectious diseases are treated by direct administration of therapeutically-effective quantities of granulocyte-macrophage colony stimulating factor employed by itself or in conjunction with an antibiotic or a sulfonamide or other immunologically effective therapeutic agents. Homogeneous granulocyte-macrophage colony stimulating factor for use in treatment in bacterial diseases is prepared by recombinant DNA techniques and then purified to homogeneity by reverse phase high-performance liquid chromatography so that it may be safely administered to subject's suffering from infectious diseases.

    摘要翻译: 患有感染性疾病的受试者通过直接施用治疗有效量的粒细胞 - 巨噬细胞集落刺激因子来治疗,所述粒细胞 - 巨噬细胞集落刺激因子本身或与抗生素或磺酰胺或其他免疫学上有效的治疗剂一起使用。 通过重组DNA技术制备用于细菌性疾病治疗的均匀粒细胞 - 巨噬细胞集落刺激因子,然后通过反相高效液相色谱纯化至均匀,从而可以安全地施用受试者感染性疾病。